No Data
No Data
United Therapeutics(UTHR.US) Officer Sells US$2.27 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 7,200 shares of common stock on Jul 5, 8, 2024 at an average price of $315.1507 for a total value of $2.27 million.Source:
Citi Research's AI Hedge Stocks - Part II
Unveiling 6 Analyst Insights On United Therapeutics
United Therapeutics (NASDAQ:UTHR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below offers a condensed view of their rece
United Therapeutics Is Maintained at Buy by UBS
United Therapeutics Is Maintained at Buy by UBS
UBS Maintains Buy on United Therapeutics, Raises Price Target to $370
UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $300 to $370.
United Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/08/2024 16.91% UBS $300 → $370 Maintains Buy 06/12/2024 10.6% Wells Fargo $325 → $350 Maintains Overwei